Long-term experience with hylan GF-20 in the treatment of knee osteoarthritis

Bibliography

• Felson DT. The epidemiology of knee osteoarthritis: results from the Framingham Osteoarthritis Study. Semin Arthritis Rheum 1990;20(3 Suppl 1):42-50
   PubMed Web of Science ®Google Scholar
• Le Pen C, Reygrobellet C, Gerentes I. Financial cost of osteoarthritis in France. The “COART” France study. Joint Bone Spine 2005;72:567-70
   PubMedGoogle Scholar
• American College of Rheumatology Subcommittee on Osteoarthritis Guidelines Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. 2000;43:1905-15
   Google Scholar
• Jordan KM, Arden NK, Doherty M, et al. EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 2003;62:1145-55
   PubMed Web of Science ®Google Scholar
• Weigel PH, Fuller GM, LeBoeuf RD. A model for the role of hyaluronic acid and fibrin in the early events during the inflammatory response and wound healing. J Theor Biol 1986;119:219-34
   PubMed Web of Science ®Google Scholar
• Borzacchiello A, Netti PA, Ambrosio L, Nicolais L. Viscoelastic properties of vitreous body: role of hyaluronic acid. XIIIth International Congress on Rheology; Cambridge, UK; 2000. p. 4365-7
   Google Scholar
• Nuki G, Ferguson J. Studies on the nature and significance of macromolecular complexes in the rheology of synovial fluid from normal and diseased human joints. Rheol Acta 1971;10:8-14
   Google Scholar
• Dahl LB, Dahl IM, Engström-Laurent A, Granath K. Concentration and molecular weight of sodium hyaluronate in synovial fluid from patients with rheumatoid arthritis and other arthropathies. Ann Rheum Dis 1985;44:817-22
   PubMed Web of Science ®Google Scholar
• Balazs EA, Watson D, Duff IF, Roseman S, Hyaluronic acid in synovial fluid. I. Molecular parameters of hyaluronic acid in normal and arthritic human fluids. Arthritis Rheum 1967;10:357-376
   PubMed Web of Science ®Google Scholar
• Balazs EA, Denlinger JL. Viscosupplementation: a new concept in the treatment of osteoarthritis. J Rheumatol 1993;20:3-9
   Web of Science ®Google Scholar
• Fam H, Bryant JT, Kontopoulou M. Rheological properties of synovial fluids. Biorheology 2007;44:59-74
   PubMed Web of Science ®Google Scholar
• Balazs EA, Analgesic effect of elastoviscous hyaluronan solutions and the treatment of arthritic pain. Matrix Biology Institute, Ridgefield, NJ, USA. Cells Tissues Organs 2003;174(1-2):49-62
   PubMed Web of Science ®Google Scholar
• Zhang W, Moskowitz RW, Nuki G, et al. OARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of current research evidence. Osteoarthritis Cartilage 2007;15:981-1000
   PubMed Web of Science ®Google Scholar
• Pendleton A, Arden N, Dougados M, et al. EULAR recommendations for the management of knee osteoarthritis: report of a task force of the standing committee for international clinical studies including therapeutic trials (ESCISIT). Ann Rheum Dis 2000;59:936-44
   PubMed Web of Science ®Google Scholar
• Lo GH, La Valley M, McAlindon T, Felson DT. Intra-articular hyaluronic acid in treatment of knee osteoarthritis. A meta-analysis. JAMA 2003;290:3115-21
   PubMed Web of Science ®Google Scholar
• Wang C-T, Lin J, Chang C-J, Lin Y-T, Hou S-M. Therapeutic effects of hyaluronic acid on osteoarthritis of the knee. A meta-analysis of randomized controlled trials. J Bone Joint Surg 2004;86-A:538-45
   PubMed Web of Science ®Google Scholar
• Bellamy N, Campbell J, Robinson V, et al. Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev 2005;2:CD005321
   Google Scholar
• Hamburger MI, Lakhanpal S, Mooar PA, Oster D. Intra-articular hyaluronans: a review of product-specific safety profiles. Semin Arthritis Rheum 2003;32:296-309
   PubMed Web of Science ®Google Scholar
• Jüni P, Reichenbach S, Trelle S, et al. Efficacy and safety of intraarticular hylan or hyaluronic acids for osteoarthritis of the knee: a randomized controlled trial. Arthritis Rheum 2007;56:3610-9
   PubMed Web of Science ®Google Scholar
• Fouissac E, Milas M, Rinaudo M, Borsali R. Influence of the ionic strength on the dimensions of sodium hyaluronate. Macromolecules 1992;25:5613-7
   Web of Science ®Google Scholar
• Berriaud N, Milas M, Rinaudo M. Rheological study on mixtures of different olecular weight hyaluronates. Int J Biol Macromol 1994;16:137-42
   PubMed Web of Science ®Google Scholar
• Lapcik L Jr, Lapcik L, de Smedt S, et al. Hyaluronan : preparation, structure, properties and applications. Chemical Rev 1998;98:2663-84
   PubMed Web of Science ®Google Scholar
• Milas M, Rinaudo M. Characterization and properties of hyaluronic acid (hyaluronan) In: Dimitriu S, editor, Polysaccharides: structural diversity and functional versatility. Dekker; 2002;22. p. 535-49
   Google Scholar
• Greenberg DD, Stoker A, Kane S, et al. Biochemical effects of two different hyaluronic acid products in a co-culture model of osteoarthritis. Osteoarthritis Cartilage 1993;1:97-103
   PubMedGoogle Scholar
• Wang CT, Lin YT, Chiang BL, et al. High molecular weight hyaluronic acid down-regulates the gene expression of osteoarthritis-associated cytokines and enzymes in fibroblast-like synoviocytes from patients with early osteoarthritis. Osteoarthritis Cartilage 2006;14:1237-47
   PubMed Web of Science ®Google Scholar
• Bagga H, Burkhardt D, Sambrook P, March L. Long term effects of intra-articular hyaluronan on synovial fluid in osteoarthritis of the knee. J Rheumatol 2006;33:946-50
   PubMed Web of Science ®Google Scholar
• Balazs EA, Leshchiner EA. Hyaluronan, its cross-linked derivative hylan and their medical applications. In: Inagaki H, Phillips HO, editors, Cellulosic utilization: research and results in cellulosics. New York: Elsevier Applied Science; 1989. p. 233-41
   Google Scholar
• Brown T, Laurent U, Manque un troisiéme auteur, et al. Turnover of hyaluronan in synovial joints: elimination of labelled hyaluronan from the knee joint of the rabbit. Exp Physiol 1991;76:125-34
   PubMed Web of Science ®Google Scholar
• Jackson D, Simon T. Intra-articular distribution and residence time of hylan A and B: a study in the goat knee. Osteoarthritis Cartilage 2006;14:1248-57
   PubMed Web of Science ®Google Scholar
• Larsen NE, Goldman AI. Residence time of Synvisc (hylan GF-20) in the rabbit knee. Biomatrix reports BXR 9010; 1997
   Google Scholar
• Sakamoto T, Mizuno S, Miyazaki K, et al. Biologicale fate of sodium hyaluronate. Studies of distribution, metabolism and excretion of 14-C SPH in rabbits after intra-articular administration. Pharmacometrics 1984;28:375-87
   Google Scholar
• Wobig M, Dickhut A, Maier R, Vetter G. Viscosupplementation with hylan G-F 20: a 26-week controlled trial of efficacy and safety in the osteoarthritic knee. Clin Ther 1998;20:410-23
   PubMed Web of Science ®Google Scholar
• Chevalier X, Jerosch L, Luyten FP, et al. A double blind, randomized, placebo controlled evaluation of the efficacy and safety of a single dose of hylan G-F 20 in patients with symptomatic osteoarthritis of the knee. Ann Rheum Dis 2007;66(Suppl II):SAT021
   Google Scholar
• Adams ME, Atkinson MH, Lussier AJ, et al. The role of viscosupplementation with hylan G-F 20 (Synvisc) in the treatment of osteoarthritis of the knee: a Canadian multicenter trial comparing hylan G-F 20 alone, hylan G-F 20 with non-steroidal anti-inflammatory drugs (NSAIDs) and NSAIDs alone. Osteoarthritis Cartilage 195;3:213-25
   Google Scholar
• Dickson DJ, Hosie G. A double blind, placebo-controlled comparison of hylan G-F 20 against diclofenac in knee osteoarthritis. J Clin Res 2001;4:41-52
   Google Scholar
• Caborn D, Rush JL, Lanzer W, et al. A randomized single blind comparison of the efficacy and tolerability of hylan GF20 and triamcinolone hexacetonide in patients with osteoarthritis of the knee. J Rheumatol 2004;31:333-43
   PubMed Web of Science ®Google Scholar
• Leopold SS, Redd BB, Warme WJ, et al. Corticosteroid compared with hyaluronic acid injections for the treatment of osteoarthritis of the knee. J Bone Joint Surg 2003;85:1197-203
   PubMedGoogle Scholar
• Olszynski WP. Effectiveness and safety of hylan GF20 compared to steroid injections patients with knee osteoarthritis. Osteoarthritis Cartilage 2003;11(Suppl A):S120
   Google Scholar
• Raynauld J-P, Torrance GW, Band PA, et al.; and the Canadian Knee OA Study Group. A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (part 1 of 2): clinical results. Osteoarthritis Cartilage 2002;10:506-17
   PubMed Web of Science ®Google Scholar
• Raynauld J-P, Goldsmith CH, Bellamy N, et al. Effectiveness and safety of repeat courses of hylan G-F 20 in patients with knee osteoarthritis. Osteoarthritis Cartilage 2005;13:111-9
   PubMed Web of Science ®Google Scholar
• Jüni P, Reichenbach S, Trelle S, et al. Efficacy and safety of intraarticular hylan or hyaluronic acids for osteoarthritis of the knee: a randomized controlled trial. Arthritis Rheum 2007;56:3610-9
   PubMed Web of Science ®Google Scholar
• Karlsson J, Sjögren LS, Lohmander LS. Comparison of two hyaluronan drugs and placebo in patients with knee osteoarthritis. A controlled, randomized, double-blind, parallel-design multicentre study. Rheumatology 2002;41:1240-8
   PubMed Web of Science ®Google Scholar
• Raman R, Dutta A, Day N, et al. Efficacy of hylan G-F 20 and sodium hyaluronate in the treatment of osteoarthritis of the knee - a prospective randomized clinical trial. Knee 2008;18 [Epub ahead of print]
   PubMedGoogle Scholar
• Kirchner M, Marshall D. A double-blind randomized controlled trial comparing alternate forms of high molecular weight hyaluronan for the treatment of osteoarthritis of the knee. Osteoarthritis Cartilage 2006;14:154-62
   PubMed Web of Science ®Google Scholar
• Reichenbach S, Blank S, Rutjes AW, et al. Hylan versus hyaluronic acid for osteoarthritis of the knee: a systematic review and meta-analysis. Arthritis Rheum 2007;57:1410-8
   PubMed Web of Science ®Google Scholar
• Modawal A, Ferrer M, Choi HK, Castle JA. Hyaluronic acid injections relieve knee pain. J Fam Pract 2005;54:758-67
   PubMed Web of Science ®Google Scholar
• Bellamy N, Campbell J, Gee T, et al. Hylan G-F 20 (SYNVISC) versus placebo: Cochrane review 2005. Ann Rheum Dis 2005;64(Suppl 3):492
   Google Scholar
• Waddell DD, Bricker DC. Clinical experience with the effectiveness and tolerability of hylan G-F 20 in 1047 patients with osteoarthritis of the knee. J Knee Surg 2006;19:19-27
   PubMedGoogle Scholar
• Waddell DD, Cefalu CA, Bricker DC. An open-label study of a second course of hylan G-F 20 for the treatment of pain associated with knee osteoarthritis. Curr Med Res Opin 2003;19:499-507
   PubMed Web of Science ®Google Scholar
• Marino AA, Waddell DD, Kolomytkin OV, et al. Assessment of immunologic mechanisms for flare reactions to Synvisc®. Clin Orthop Relat Res 2006;442:187-94
   PubMedGoogle Scholar
• Hamburger M, Settles M, Teutsch J. Identification of an immunogenic candidate for the elicitation of severe acute inflammatory reactions (SAIRs) to hylan G-F 20. Osteoarthritis Cartilage 2005;13:266-8
   PubMedGoogle Scholar
• Conrozier T, Mathieu P, Schott AM, et al. Factors predicting long-term efficacy of hylan G-F 20 viscosupplementation in knee osteoarthritis. Joint Bone Spine 2003;70:128-33
   PubMed Web of Science ®Google Scholar
• Lussier A, Cividino AA, McFarlane CA, et al. Viscosupplementation with hylan for the treatment of osteoarthritis: findings from clinical practice in Canada. J Rheumatol 1996;23:1579-85
   PubMed Web of Science ®Google Scholar
• Toh EM, Prasad PS, Teanby D. Correlating the efficacy of knee viscosupplementation with osteoarthritic changes on roentgenological examination. Knee 2002;9:321-30
   PubMedGoogle Scholar
• Conrozier T, Jerosch J, Beks P, et al. randomised evaluation of the safety and efficacy of five dosing regimens of viscosupplementation with hylan G-F 20 in patients with symptomatic tibio-femoral osteoarthritis: a pilot study. Arch Orthop Trauma Surg 2008 [Epub ahead of print]
   Google Scholar
• Kahan A, Lleu PL, Salin L. Prospective randomized study comparing the medicoeconomic benefits of Hylan GF-20 vs. conventional treatment in knee osteoarthritis. Joint Bone Spine 2003;70:276-81
   PubMed Web of Science ®Google Scholar
• Conrozier T, Bertin P, Mathieu P, et al. Intra-articular injections of hylan G-F 20 in patients with symptomatic hip osteoarthritis: an open-label, multicentre, pilot study. Clin Exp Rheumatol 2003;21:605-10
   PubMed Web of Science ®Google Scholar
• Conrozier T, Bertin B, Bailleul F, et al. Clinical response to intra-articular injections of hylan g-f 20 in symptomatic hip osteoarthritis: the OMERACT-OARSI criteria applied to the results of a pilot study. Joint Bone Spine 2006;73:705-9
   PubMed Web of Science ®Google Scholar
• Weiss C, Band P. Musculoskeletal applications of hyaluronan and hylan. Potential uses in the foot and ankle. Clin Podiatr Med Surg 1995;12:497-517
   PubMedGoogle Scholar
• Valiveti M, Reginato AJ, Falasca GF. Viscosupplementation for degenerative joint disease of shoulder and ankle. J Clin Rheumatol 2006;12:162-3
   PubMedGoogle Scholar
• Jackson DW, Evans NA, Thomas BAN. Accuracy of needle placement into the intra-articular space of the knee. J Bone Joint Surg Am 2002;84:1522-7
   PubMed Web of Science ®Google Scholar